酒石酸美托洛尔联合通心络胶囊治疗冠心病心绞痛的效果观察.docVIP

酒石酸美托洛尔联合通心络胶囊治疗冠心病心绞痛的效果观察 　　[摘要] 目的 探讨酒石酸美托洛尔联合通心络胶囊治疗冠心病心绞痛的临床效果。 方法 选取2012年1月～2014年1月本院收治的冠心病心绞痛患者140例，将其随机分为观察组和对照组各70例，两组均给予常规治疗，对照组在常规治疗的基础上加用酒石酸美托洛尔，观察组在对照组治疗的基础上加用通心络胶囊，比较两组的临床疗效。 结果 观察组总有效率为88.57%，对照组总有效率为45.71%，两组差异有统计学意义（P0.05）。观察组心电图改变总有效率为94.28%，对照组心电图改变总有效率为52.86%，两组差异有统计学意义（P0.05）。 结论 酒石酸美托洛尔联合通心络胶囊治疗冠心病心绞痛效果显著，可明显改善患者的临床症状，值得临床推广应用。 　　[关键词] 酒石酸美托洛尔；通心络胶囊；冠心病；心绞痛 　　[中图分类号] R972 [文献标识码] A [文章编号] 1674-4721（2014）08（a）-0073-02 　　Efficacy observation of metoprolol tartaric acid combined with Tongxinluo capsule in treatment of coronary heart disease angina 　　FANG Jing 　　The First Department of Medicine，the Central Hospital of Tunhe District in Urumqi，Xinjiang Uygur Autonomous Region，Urumqi 830023，China 　　[Abstract] Objective To investigate the clinical effect of metoprolol tartaric acid combined with Tongxinluo capsule in treatment of coronary heart disease angina. Methods 140 cases of patients with coronary heart disease angina treated in our hospital from January 2012 to January 2014 were selected and were randomly divided into observation group （70 cases） and control group （70 cases）.All patients were given the routine treatment，on which，metoprolol tartaric acid was given to control group，while Tongxinluo capsule was added to observation group.The clinical efficacy of two groups were compared. Results The total effective rate of observation group was 88.57%，which was 45.71% of control group，the difference was significant （P0.05）.ECG total effective rate of observation group was 94.28%，which was 52.86% of control group，the difference was significant （P0.05）. Conclusion Metoprolol tartaric acid combined with Tongxinluo capsule in treatment of coronary heart disease angina has a good treatment effect，it can improve the clinical symptoms of patients，be worthy of clinical application. 　　[Key words] Metoprolol tartaric acid；Tongxinluo capsule；Coronary heart disease；Angina 　　冠心病是因冠状动脉硬化、堵塞导致的急性心肌缺血，常导致心绞痛的发生[1]，不仅影响日常生活质量，严重时可导致患者猝死。本研究探讨酒石酸美托洛尔联合